Akorn, Inc

Chemical Management

Businesswire | May 05, 2023

We are excited to announce a new partnership between Innovassynth and Actylis, two industry-leading companies offering Custom synthesis, Contract manufacturing and off-the-shelf products to the Pharmaceutical and Life Sciences industry. This collaboration will allow Actylis to add Innovassynth’s portfolio of nucleosides to its range of critical raw materials. Innovassynth, India, is a Custom Development & Manufacturing Organization (CDMO) and a trusted partner to Pharm...

Chemical Technology

GenCell Energy | February 28, 2022

GenCell Energy the leading provider of hydrogen and ammonia to power solutions, announces that in continuation from the Company's Immediate Release dated February 23, 2021 regarding the participation of the Japanese technology provider TDK Corporation in the Company's innovative, zero-emission green ammonia synthesis project, the Company is now proud to announce achievement of a significant scientific breakthrough which enables the production of green ammonia directly from water at very ...

Chemical Management

BASF Corporation | August 05, 2022

BASF has announced it will produce more 2-Pyrrolidone and N-Octyl-2-Pyrrolidone (NOP) at its Geismar, Louisiana, Verbund site. The production is anticipated to be on-stream in the second half of 2022 and will ensure a global supply of HEP and NOP. "Our customers want to continue to grow in the ink, automotive and agricultural markets and will need increasing quantities for the foreseeable future. We can accompany these growth plans thanks to our double-d...

STAT | March 10, 2020

The push to increase testing in the U.S. for the novel coronavirus that causes Covid-19 has hit a new stumbling block: shortages of key chemicals needed to start up and run the tests. In particular, one key product, made by the diagnostics testing giant Qiagen, is in dwindling supply. The chemical is used to isolate the virus’ genetic material, or RNA, so that it can be tested. Robert Redfield, the director of the Centers for Disease Control and Prevention, told Politico, which first repor...